S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
Log in

NASDAQ:HQY - Healthequity Stock Price, Forecast & News

$75.70
-1.13 (-1.47 %)
(As of 02/26/2020 04:00 PM ET)
Today's Range
$74.94
Now: $75.70
$78.87
50-Day Range
$66.06
MA: $73.92
$87.73
52-Week Range
$50.87
Now: $75.70
$88.78
Volume632,775 shs
Average Volume733,165 shs
Market Capitalization$5.37 billion
P/E Ratio88.02
Dividend YieldN/A
Beta1.44
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. Read More…

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HQY
CUSIPN/A
Phone801-727-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$287.24 million
Cash Flow$1.14 per share
Book Value$7.65 per share

Profitability

Net Income$73.90 million

Miscellaneous

Employees1,141
Market Cap$5.37 billion
Next Earnings DateN/A
OptionableOptionable

Receive HQY News and Ratings via Email

Sign-up to receive the latest news and ratings for HQY and its competitors with MarketBeat's FREE daily newsletter.


Healthequity (NASDAQ:HQY) Frequently Asked Questions

What is Healthequity's stock symbol?

Healthequity trades on the NASDAQ under the ticker symbol "HQY."

How were Healthequity's earnings last quarter?

Healthequity Inc (NASDAQ:HQY) announced its earnings results on Tuesday, December, 3rd. The company reported $0.47 earnings per share for the quarter, beating analysts' consensus estimates of $0.14 by $0.33. The business had revenue of $157.12 million for the quarter, compared to the consensus estimate of $152.38 million. Healthequity had a net margin of 13.03% and a return on equity of 11.31%. Healthequity's quarterly revenue was up 122.9% on a year-over-year basis. During the same period last year, the firm posted $0.25 earnings per share. View Healthequity's Earnings History.

What guidance has Healthequity issued on next quarter's earnings?

Healthequity issued an update on its FY20 earnings guidance on Tuesday, February, 18th. The company provided earnings per share guidance of $1.71-1.73 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.51. The company issued revenue guidance of $530-532 million, compared to the consensus revenue estimate of $524.35 million.

What price target have analysts set for HQY?

12 equities research analysts have issued 12-month target prices for Healthequity's shares. Their forecasts range from $56.00 to $95.00. On average, they expect Healthequity's share price to reach $81.18 in the next year. This suggests a possible upside of 7.2% from the stock's current price. View Analyst Price Targets for Healthequity.

What is the consensus analysts' recommendation for Healthequity?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthequity in the last year. There are currently 1 hold rating, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Healthequity.

Has Healthequity been receiving favorable news coverage?

Media coverage about HQY stock has been trending somewhat positive on Wednesday, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Healthequity earned a news impact score of 1.1 on InfoTrie's scale. They also gave news articles about the company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an impact on the stock's share price in the next several days. View News Stories for Healthequity.

Are investors shorting Healthequity?

Healthequity saw a increase in short interest during the month of February. As of February 14th, there was short interest totalling 6,420,000 shares, an increase of 13.8% from the January 30th total of 5,640,000 shares. Based on an average daily trading volume, of 722,400 shares, the days-to-cover ratio is currently 8.9 days. Approximately 9.3% of the company's stock are short sold. View Healthequity's Current Options Chain.

Who are some of Healthequity's key competitors?

What other stocks do shareholders of Healthequity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Healthequity investors own include NVIDIA (NVDA), Input Capital (INP), Circle Oil (COP), Shopify (SHOP), Alibaba Group (BABA), Paypal (PYPL), Netflix (NFLX), Twilio (TWLO), Square (SQ) and Okta (OKTA).

Who are Healthequity's key executives?

Healthequity's management team includes the folowing people:
  • Mr. Jon Kessler, Pres, CEO & Director (Age 51)
  • Stephen D. Neeleman, Founder & Vice Chairman (Age 51)
  • Mr. Darcy G. Mott, Exec. VP & CFO (Age 66)
  • Ms. Ashley Dreier, Exec. VP, CTO & Chief Information Officer (Age 46)
  • Mr. William Robert Otten, Exec. VP of Sales (Age 54)

Who are Healthequity's major shareholders?

Healthequity's stock is owned by many different of institutional and retail investors. Top institutional investors include FMR LLC (5.55%), Jackson Square Partners LLC (5.04%), Janus Henderson Group PLC (3.37%), State Street Corp (3.09%), Fred Alger Management LLC (2.53%) and Bamco Inc. NY (1.49%). Company insiders that own Healthequity stock include Angelique Christine Hill, Ashley Dreier, Darcy G Mott, Delano Ladd, Evelyn S Dilsaver, Frank Corvino, Frank Medici, Gary D Robinson, Jon Kessler, Jon Soldan, Larry L Trittschuh and Stephen Neeleman. View Institutional Ownership Trends for Healthequity.

Which institutional investors are selling Healthequity stock?

HQY stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Jennison Associates LLC, Geode Capital Management LLC, Royce & Associates LP, AQR Capital Management LLC, Hodges Capital Management Inc., Moody Lynn & Lieberson LLC and Panagora Asset Management Inc.. Company insiders that have sold Healthequity company stock in the last year include Angelique Christine Hill, Ashley Dreier, Darcy G Mott, Delano Ladd, Frank Corvino and Larry L Trittschuh. View Insider Buying and Selling for Healthequity.

Which institutional investors are buying Healthequity stock?

HQY stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Fred Alger Management LLC, Janus Henderson Group PLC, Jackson Square Partners LLC, Raymond James Financial Services Advisors Inc., Raymond James & Associates, Echo Street Capital Management LLC and Bank of Montreal Can. View Insider Buying and Selling for Healthequity.

How do I buy shares of Healthequity?

Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Healthequity's stock price today?

One share of HQY stock can currently be purchased for approximately $75.70.

How big of a company is Healthequity?

Healthequity has a market capitalization of $5.37 billion and generates $287.24 million in revenue each year. The company earns $73.90 million in net income (profit) each year or $0.95 on an earnings per share basis. Healthequity employs 1,141 workers across the globe.View Additional Information About Healthequity.

What is Healthequity's official website?

The official website for Healthequity is http://www.healthequity.com/.

How can I contact Healthequity?

Healthequity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company can be reached via phone at 801-727-1000 or via email at [email protected]


MarketBeat Community Rating for Healthequity (NASDAQ HQY)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  426 (Vote Outperform)
Underperform Votes:  337 (Vote Underperform)
Total Votes:  763
MarketBeat's community ratings are surveys of what our community members think about Healthequity and other stocks. Vote "Outperform" if you believe HQY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HQY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Featured Article: Depreciation

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel